We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Neurology |

Highlights FREE

JAMA Neurol. 2014;71(9):1069. doi:10.1001/jamaneurol.2013.4166.
Text Size: A A A
Published online


Fu and colleagues investigate whether oral administration of fingolimod, a Food and Drug Administration–approved sphingosine 1–phosphate receptor modulator for multiple sclerosis, is safe and effective in alleviating perihematomal edema (PHE) and neurologic deficits in patients with intracerebral hemorrhage (ICH). They included 23 patients with primary supratentorial ICH with hematomal volume of 5 to 30 mL. They report that in patients with small- to moderate-sized deep primary supratentorial ICH, administration of oral fingolimod within 72 hours of disease onset was safe, reduced PHE, attenuated neurologic deficits, and promoted recovery. Editorial perspective is provided by Kevin N. Sheth, MD, and Jonathan Rosand, MD, MSc.

Fitzgerald and coauthors examine the association between ω-6 and ω-3 polyunsaturated fatty acids (PUFA) consumption and amyotrophic lateral sclerosis (ALS) risk. Diet was assessed via food frequency questionnaire developed or modified for each cohort. They find that consumption of foods high in ω-3 PUFAs may help prevent or delay the onset of ALS. Editorial perspective is provided by Michael Swash, MD.

Thomas et al assess the similarities and differences in functional connectivity changes owing to autosomal dominant Alzheimer disease (ADAD) and late-onset AD (LOAD). They analyzed functional connectivity in multiple brain resting state networks in a cross-sectional cohort of participants with ADAD (n = 79) and LOAD (n = 444), using resting-state functional connectivity magnetic resonance imaging at multiple international academic sites. They show resting-state functional connectivity magnetic resonance imaging changes with progressing AD severity are similar between ADAD and LOAD. Editorial perspective is provided by Adam S. Fleisher, MD, MAS.

Sauser and colleagues examine the contributions of door-to-imaging time (DIT) and imaging-to-needle (ITN) time to delays in timely delivery of tissue plasminogen activator (tPA) to patients with acute ischemic stroke and assess between-hospital variation in DTN times. They analyzed a cohort of 1193 patients having acute ischemic stroke treated with intravenous tPA between January 2009 and December 2012. Compared with DIT, ITN time is a much greater source of variability in hospital DTN times and is a more common contributor to delays in timely tPA therapy for acute ischemic stroke.

Kara and coauthors report a novel family carrying a heterozygous 6.4 Mb duplication of the SNCA locus with an atypical clinical presentation strongly reminiscent of frontotemporal dementia and late-onset pallidopyramidal syndromes and study phenotype-genotype correlations in SNCA locus duplications. They report the clinical and neuropathologic features of this family. These findings further expand the phenotypic spectrum of SNCA locus duplications.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.